Levagen
Natural health product licensed in Canada
- Licence holder
- Barentz Canada ULC
- NPN or DIN-HM
- 80114041
- Status
- Active licence
- Licence date
- 8 November 2021
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-(2-Hydroxyéthyl)hexadécanamide Source : Synthétique | 150 mg | Not calculated |
Non-medicinal ingredients
Phosphate dicalcique, Stéarate de magnésium, Silice, Cellulose microcristalline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | minimum: 1 Capsule ; maximum: 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve pain and stiffness associated with mild knee osteoarthritis.Clinically shown to help relieve minor pain and stiffness associated with knee osteoarthritis.Decreases/reduce/helps relieves symptoms of pain and stiffness associated with knee osteoarthritis.Decreases/reduces/helps relieves mild knee joint pain/soreness associated with knee osteoarthritis.Decreases/reduces/helps relieves mild knee joint aches and pains associated with knee osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80114041
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.